← Eichor
Study identifier: NCT04982419 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

Condition: Acute Kidney Injury · Heart Failure · Contrast Induced Nephropathy  ·  Sponsor: VA Office of Research and Development

PhasePhase 2/Phase 3
Planned participants240
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in in patients with congestive heart failure undergoing cardiac catheterization and/or percutaneous coronary intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Oladipupo Olafiranye, MD MS  ·  (214) 857-2923  ·  Oladipupo.Olafiranye@va.gov

Always discuss trial participation with your own doctor first.

Locations (3)

VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PAPittsburgh, Pennsylvania, United StatesRecruiting
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TXDallas, Texas, United StatesRecruiting
Hunter Holmes McGuire VA Medical Center, Richmond, VARichmond, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04982419